BIOCRYST PHARMACEUTICALS, INC.

Company

BIOCRYST PHARMACEUTICALS INC

Filed

April 10, 2007

Period of Report

May 16, 2007

Accession Number

0000950144-07-003266

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →